Effective January 1, 2019, Spectrum Health Regional Laboratory will no longer offer Magnesium, Red Blood Cell [LAB104] as an option for send out testing. This testing will no longer be available through Spectrum Health’s primary reference laboratory, Mayo Clinic Laboratories. This test will become obsolete on January 7, 2019, due to limited clinical utility.
As of May 8, 2018, the following tests are no longer performed by Spectrum Health Laboratory. These tests are now available through Mayo Medical Laboratories as a send out. Please note that the specimen collection for these tests may have changed. Please check the Laboratory Catalog for collection information.
|Discontinued Test Code||Discontinue Test Name||Replacement Code||Replacement Name|
|LAB752||Clomipramine Level||LAB1230481||Clomipramine, Serum|
|LAB683||Ethosuximide Level||LAB1230480||Ethosuximide, Serum|
Questions may be directed to the Toxicology Department using the “Contact Us” link above.
On March 21, 2017, Spectrum Health Regional Laboratory (SHRL) will be switching instrument/vendors that perform the Beta CTX (BCTX assay); we will be switching from the ROCHE COBAS® platform to the ISYS-IDS platform. Both methods compare very well, however reference ranges will change due to the different methods.
As of March 13th, 2017 Spectrum Health Regional Laboratory will be inactivating the CK Isoenzyme orderable (SH # 2799, Epic #LAB64). This test is not necessary in patients with clinically consistent CK elevations such as, but not limited to, muscle disease, muscle injury or statin use. In cases of suspected statin myopathy/myositis, elevated CK coupled with statin use is enough to make the diagnosis. CK Isoenzyme testing is recommended in situations where the CK elevation cannot be explained by clinical history and physical. Moving forward, CK Isoenzyme requests will require approval from either Dr. Alter or Dr. Blue.
Any questions concerning this change may be directed to Dr. David Alter or Dr. Deborah Blue via the “Contact Us” link.